Subscribe to our newsletter.
Introducing the Viennalab TPMT StripAssay® Kit – the crucial solution for accurate identification of the most frequent TPMT variants affecting the metabolism of thiopurine-based therapeutic drugs. Our kit enables clinicians to identify TPMT variants of therapeutic relevance, enabling personalized treatment to individual patient needs.
Thiopurines are commonly used in the treatment of leukemias and autoimmune disorders, as well as in immunosuppression therapy after organ transplantation. However, patients carrying certain genetic variants of the drug-metabolizing enzyme TPMT are at risk of thiopurine toxicity due to the accumulation of the drug to toxic levels.
The Viennalab TPMT StripAssay® Kit identifies the most frequent TPMT variants of therapeutic relevance, enabling clinicians to personalize the thiopurine dosage to individual patient needs. By accurately identifying the patient’s TPMT isoform, clinicians can avoid toxic effects and prevent life-threatening conditions.
Trust in Viennalab’s expertise and experience in molecular diagnostics to provide you with reliable and easy-to-use results for your laboratory workflow. Take the first step towards achieving personalized thiopurine-based therapy and improving patient outcomes – add the Viennalab TPMT StripAssay® Kit to your laboratory today.
The kit also includes instructions for use, as well as a protocol for the detection of SNPs in the TPMT gene using the StripAssay format.